Skip to main contentSkip to navigation
Sirius Investors
American Oncology Network, Inc.

American Oncology Network, Inc.

AONC
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for AONC. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
69.41M
-75.79% over period
CAGR: -29.84%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
153.93M
-46.30% over period
CAGR: -14.39%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Dec 31, 2024

EV/EBITDA

Potentially Rich

16.18x

Higher EV/EBITDA may imply premium pricing; growth durability should justify the multiple.

EV vs Market Cap Spread

84.52M

EV is +121.8% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +121.8 pp vs earliest data

Additional Multiples

EV/Sales: 0.31x

Net Debt/EBITDA: 8.95x

Share count change in dataset: -54.06%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202469.41M153.93M$5.0613.72M
Dec 31, 202339.45M139.23M$5.906.69M
Dec 31, 2022418.96M519.17M$10.0541.69M
Dec 31, 2021
Dec 31, 2020

Enterprise Value Analysis

Price Change (Dec 2023 to Dec 2024)

The stock price has decreased from Dec 2023 to Dec 2024.
-14.24%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.18

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-0.71

Market Cap Change (Dec 2023 to Dec 2024)

The company's market capitalization has increased from Dec 2023 to Dec 2024.
+75.95%

Enterprise Value Change (Dec 2023 to Dec 2024)

The company's enterprise value has increased from Dec 2023 to Dec 2024, suggesting growth in the company's total economic value.
+10.55%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-29.84%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-14.39%